Table 3 Haemodynamic data in the sufentanil and remifentanil group after atropine administration
|  |  | T0 | T4 | ∆ | P - value* |
|---|---|---|---|---|---|
MAP (mmHg) | Sufentanil | 69 (63 to 81) | 72 (67 to 80) | 4 (−2 to 9) | 0.101 |
|  | Remifentanil | 67 (56 to 78) | 64 (57 to 77) | 1 (−2 to 6) | 0.942 |
HR (bpm) | Sufentanil | 57 (49 to 59) | 70 (63 to 74) | 13 (9 to 19) | < 0.001 |
|  | Remifentanil | 53 (50 to 58) | 64 (56 to 70) | 9 (6 to 14) | < 0.001 |
SV (ml) | Sufentanil | 69 ± 17 | 67 ± 23 | −3 ± 10 | 0.253 |
|  | Remifentanil | 63 ± 14 | 59 ± 12 | −4 ± 11 | 0.110 |
CI (l min−1 m−2) | Sufentanil | 2.0 ± 0.5 | 2.3 ± 0.8 | 0.4 ± 0.4 | 0.001 |
|  | Remifentanil | 1.7 ± 0.3 | 1.9 ± 0.4 | 0.2 ± 0.3 | 0.032 |
RPP (mmHg bpm) | Sufentanil | 5590 ± 918 | 7173 ± 1589 | 1584 ± 1413 | < 0.001 |
|  | Remifentanil | 5204 ± 1053 | 6014 ± 1590 | 810 ± 917 | 0.001 |
SctO2 (%) | Sufentanil | 73 (68 to 79) | 73 (65 to 78) | −2 (−3 to 1) | 0.120 |
|  | Remifentanil | 72 (66 to 75) | 69 (65 to 74) | -2 (−2 to −1) | 0.005 |
SptO2 (%) | Sufentanil | 88 (81 to 91) | 88 (83 to 91) | 1 (−1 to 2) | 0.582 |
|  | Remifentanil | 83 (78 to 86) | 81 (77 to 86) | 0 (−1 to 0) | 0.471 |